Baricitinib treatment
Showing 1 - 25 of 144
Rheumatoid Arthritis Trial in Dhaka (Baricitinib 2 MG, Methotrexate 25mg)
Recruiting
- Rheumatoid Arthritis
- Baricitinib 2 MG
- Methotrexate 25mg
-
Dhaka, BangladeshDr. Md. Abu Shahin
Apr 12, 2023
Traumatic Brain Injury Trial in Xi'an (Baricitinib 4 MG, Standard treatment)
Not yet recruiting
- Traumatic Brain Injury
- Baricitinib 4 MG
- Standard treatment
-
Xi'an, Shaanxi, ChinaTandu Hospital, Fourth Military Medical University
Sep 26, 2023
Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)
Recruiting
- Axial Spondyloarthritis
- Baricitinib 2mg
- Tofacitinib 5 mg
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Nov 1, 2023
NMO Spectrum Disorder Trial in Tianjin (Baricitinib)
Not yet recruiting
- NMO Spectrum Disorder
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Mar 18, 2023
Mastitis Chronic, Idiopathic Granulomatous Mastitis Trial in Hangzhou (Baricitinib)
Recruiting
- Mastitis Chronic
- Idiopathic Granulomatous Mastitis
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
May 9, 2023
Rheumatoid Arthritis Trial in Dhaka (Baricitinib 4 MG, Baricitinib 2 MG)
Recruiting
- Rheumatoid Arthritis
- Baricitinib 4 MG
- Baricitinib 2 MG
-
Dhaka, [Other], BangladeshDr. Md. Sadikul islam
Dec 13, 2022
IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)
Recruiting
- IgG4-related Disease With Eosinophilia
-
Beijing, Bejing, ChinaPeking Union Medical College Hospital
Mar 23, 2023
Rheumatoid Arthritis Trial in Paris (Baricitinib Oral Tablet [Olumiant], Placebo)
Recruiting
- Rheumatoid Arthritis
- Baricitinib Oral Tablet [Olumiant]
- Placebo
-
Paris, FranceCHU Pitié Salpêtrière
Aug 22, 2022
Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)
Not yet recruiting
- Atopic Dermatitis
- Baricitinib 4 MG
- Azathioprine 1.5-2.5 mg/kg
-
Sari, Mazandaran, Iran, Islamic Republic ofIran
Aug 1, 2023
Active Non-anterior Non-infectious Uveitis Trial (Baricitinib 4 MG)
Not yet recruiting
- Active Non-anterior Non-infectious Uveitis
- Baricitinib 4 MG
- (no location specified)
Dec 7, 2022
ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)
Recruiting
- ITP
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 27, 2022
Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)
Recruiting
- Lupus or SLE
- Nephritis
- Baricitinib 4 MG
- +2 more
-
Assiut, Yes, EgyptManal Hassanien
Jan 13, 2023
Human Immunodeficiency Virus Trial in Atlanta (Baricitinib 2 MG Oral Tablet, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- Baricitinib 2 MG Oral Tablet
- Placebo
-
Atlanta, Georgia
- +1 more
Aug 11, 2022
Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)
Recruiting
- Sjogren's Syndrome
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 17, 2022
Post-Acute COVID-19 Syndrome Trial in United States (Baricitinib 4 MG)
Not yet recruiting
- Post-Acute COVID-19 Syndrome
- Baricitinib 4 MG
-
San Francisco, California
- +5 more
May 11, 2023
Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)
Active, not recruiting
- Chronic Graft vs Host Disease
- Chronic Graft-Versus-Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 29, 2022
Dermatomyositis Trial in Paris (Baricitinib, Placebo)
Not yet recruiting
- Dermatomyositis
- Baricitinib
- Placebo
-
Paris, FrancePitie-Salpêtrière hospital APHP
Jun 7, 2022
Idiopathic Inflammatory Myopathies Trial in London (Baricitinib)
Recruiting
- Idiopathic Inflammatory Myopathies
-
London, United KingdomKing's College Hospital NHS Foundation Trust
May 19, 2022
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)
Not yet recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG [Olumiant]
- Danazol
-
Beijing, Beijing, China
- +9 more
May 2, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)
Recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG
- Dexamethasone
-
Beijing, China
- +9 more
Jul 11, 2023
Dermatomyositis Trial in Seattle (Baricitinib)
Not yet recruiting
- Dermatomyositis
-
Seattle, WashingtonUniversity of Washington Medical Center
Apr 29, 2022
COVID-19 Trial in Patras (Tocilizumab, Baricitinib)
Recruiting
- COVID-19
-
Patras, GreeceUniversity Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022
Arteritis, Giant Cell Trial in Rochester (Baricitinib)
Completed
- Arteritis, Giant Cell
-
Rochester, MinnesotaMayo Clinic
Apr 7, 2022